Literature DB >> 22562824

Hypoxia-induced vasculogenic mimicry formation via VE-cadherin regulation by Bcl-2.

Nan Zhao1, Bao-cun Sun, Tao Sun, Yue-mei Ma, Xiu-lan Zhao, Zhi-yong Liu, Xue-yi Dong, Na Che, Jing Mo, Qiang Gu.   

Abstract

Vasculogenic mimicry (VM) refers to the unique ability of highly aggressive tumor cells to mimic the pattern of embryonic vasculogenic networks. Hypoxia plays a pivotal role in the formation of VM. Hypoxia-induced Bcl-2 overexpression is observed in many types of tumors including melanoma, in which it is associated with tumorigenicity and angiogenesis. VE-cadherin, the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation, is also overexpressed in melanoma. Despite these connections, whether hypoxia induces VM formation via VE-cadherin regulation by Bcl-2 is not confirmed. We used human melanoma cells to upregulate or knockdown the expression of Bcl-2 to investigate the possible molecular mechanism of VM formation under hypoxia. Bcl-2 overexpression increased VE-cadherin expression and VM formation under normoxia, whereas Bcl-2 siRNA significantly decreased VE-cadherin expression and VM formation under hypoxia. We then demonstrated that Bcl-2 regulated VE-cadherin transcription activity by Western blot, three-dimensional cultures, reporter gene assay, and clinical analysis. Therefore, Bcl-2-dependent VE-cadherin overexpression may be an important mechanism by which hypoxia induces VM.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22562824     DOI: 10.1007/s12032-012-0245-5

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  40 in total

Review 1.  In vitro models of vasculogenesis and angiogenesis.

Authors:  B Vailhé; D Vittet; J J Feige
Journal:  Lab Invest       Date:  2001-04       Impact factor: 5.662

Review 2.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

3.  BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study.

Authors:  L Rieger; M Weller; A Bornemann; M Schabet; J Dichgans; R Meyermann
Journal:  J Neurol Sci       Date:  1998-02-18       Impact factor: 3.181

4.  ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.

Authors:  Paul Mak; Irwin Leav; Bryan Pursell; Donggoo Bae; Xiaofang Yang; Cherie A Taglienti; Lindsey M Gouvin; Vishva M Sharma; Arthur M Mercurio
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

5.  Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis.

Authors:  Jianhong Zuo; Tohru Ishikawa; Shadi Boutros; Zhiqiang Xiao; Joseph O Humtsoe; Randall H Kramer
Journal:  Mol Cancer Res       Date:  2010-02-09       Impact factor: 5.852

6.  Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth.

Authors:  Daniela Trisciuoglio; Marianna Desideri; Ludovica Ciuffreda; Marcella Mottolese; Domenico Ribatti; Angelo Vacca; Mario Del Rosso; Lucia Marcocci; Gabriella Zupi; Donatella Del Bufalo
Journal:  J Cell Physiol       Date:  2005-12       Impact factor: 6.384

7.  Hypoxic induction of HIF-1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases.

Authors:  Babak Shemirani; David L Crowe
Journal:  Oral Oncol       Date:  2002-04       Impact factor: 5.337

8.  HIF, stretching to get control of VEGF.

Authors:  Timothy D Warner; Jane A Mitchell
Journal:  Clin Sci (Lond)       Date:  2003-10       Impact factor: 6.124

Review 9.  VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation.

Authors:  Dietmar Vestweber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-12-27       Impact factor: 8.311

10.  Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes.

Authors:  M Lam; G Dubyak; L Chen; G Nuñez; R L Miesfeld; C W Distelhorst
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

View more
  19 in total

1.  Vasculogenic mimicry and aberrant expression of HIF-lα/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma.

Authors:  Da-Min Chai; Zheng-Qi Bao; Jian-Guo Hu; Li Ma; Zhen-Zhong Feng; Yi-Sheng Tao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

2.  Clinical significance of vasculogenic mimicry, vascular endothelial cadherin and SOX4 in patients with esophageal squamous cell carcinoma.

Authors:  Yanzi Qin; Wenjun Zhao; Lili Cheng; Shiwu Wu; Qiong Wu; Jin Gao; Zhaonan Bian; Li Ma
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

Review 3.  Vascular mimicry: Triggers, molecular interactions and in vivo models.

Authors:  Stephen L Wechman; Luni Emdad; Devanand Sarkar; Swadesh K Das; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2020-07-16       Impact factor: 6.242

Review 4.  Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.

Authors:  Xiaoxu Wei; Yunhua Chen; Xianjie Jiang; Miao Peng; Yiduo Liu; Yongzhen Mo; Daixi Ren; Yuze Hua; Boyao Yu; Yujuan Zhou; Qianjin Liao; Hui Wang; Bo Xiang; Ming Zhou; Xiaoling Li; Guiyuan Li; Yong Li; Wei Xiong; Zhaoyang Zeng
Journal:  Mol Cancer       Date:  2021-01-04       Impact factor: 27.401

5.  HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.

Authors:  Na-Na Tang; Hong Zhu; Hong-Jie Zhang; Wei-Feng Zhang; Hai-Lin Jin; Lu Wang; Pin Wang; Gui-Jun He; Bo Hao; Rui-Hua Shi
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

6.  Mechanisms of tubulogenesis and endothelial phenotype expression by MSCs.

Authors:  Julie A Rytlewski; M Alejandra Aldon; Evan W Lewis; Laura J Suggs
Journal:  Microvasc Res       Date:  2015-02-21       Impact factor: 3.514

7.  N-cadherin participated in invasion and metastasis of human esophageal squamous cell carcinoma via taking part in the formation of vasculogenic mimicry.

Authors:  Feng Wang; Xiang-Ke Li; Hong-Yan Xu; Zheng-Zheng Shan; Tao Wang; Zi-Chang Yang; Wei He; Liu-Xing Wang; Qing-Xia Fan
Journal:  Med Oncol       Date:  2015-01-10       Impact factor: 3.064

Review 8.  Vascular mimicry: changing the therapeutic paradigms in cancer.

Authors:  Nazila Fathi Maroufi; Sina Taefehshokr; Mohammad-Reza Rashidi; Nima Taefehshokr; Mahdieh Khoshakhlagh; Alireza Isazadeh; Narmin Mokarizadeh; Behzad Baradaran; Mohammad Nouri
Journal:  Mol Biol Rep       Date:  2020-05-18       Impact factor: 2.316

9.  The Chk2-PKM2 axis promotes metabolic control of vasculogenic mimicry formation in p53-mutated triple-negative breast cancer.

Authors:  Pei Yu; Xiong Zhu; Jia-Le Zhu; Yu-Bao Han; Hao Zhang; Xiang Zhou; Lei Yang; Yuan-Zheng Xia; Chao Zhang; Ling-Yi Kong
Journal:  Oncogene       Date:  2021-07-09       Impact factor: 9.867

10.  Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets.

Authors:  Jin-Ming Mao; Jing Liu; Geng Guo; Xing-Gang Mao; Chang-Xin Li
Journal:  Biomark Res       Date:  2015-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.